Snapshot

The Priority Assessment of New Medicine Applications pathway has been developed by the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) of New Zealand.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Target time assessment is Evaluation Timeframes: https://www.medsafe.govt.nz/regulatory/EvaluationTimeframesAndRegistrationSituation.asp .